A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Chronic Drug-resistant Temporal Lobe Epilepsy - The SeLECT Study
收藏Figshare2023-07-06 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/A_Phase_2_Randomised_Controlled_Trial_of_Sodium_Selenate_as_a_Disease_Modifying_Treatment_for_Chronic_Drug-resistant_Temporal_Lobe_Epilepsy_-_The_SeLECT_Study/23632326
下载链接
链接失效反馈官方服务：
资源简介：
Sodium selenate, 15mg three times a day, 26 weeks, oral tablet. Participants will be required to return unused tablets to site each visit to monitor compliance with dosing regimen.
创建时间：
2023-07-06
